Haemonetics (HAE) Total Debt (2010 - 2026)

Haemonetics has reported Total Debt for 17 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Debt changed 0.02% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (changed 0.02% YoY), and the FY2026 full-year result was $1.2 billion, changed 0.02% from the prior year.
• Total Debt for Q1 2026 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
• The five-year high for Total Debt was $1.2 billion in Q3 2024, with the low at $762.2 million in Q3 2023.
• Average Total Debt over 5 years is $981.9 million, with a median of $844.2 million recorded in 2022.
• Year-over-year, Total Debt soared 150.89% in 2022 and dropped 6.79% in 2023.
• Tracing HAE's Total Debt over 5 years: stood at $766.8 million in 2022, then rose by 13.54% to $870.6 million in 2023, then surged by 40.69% to $1.2 billion in 2024, then retreated by 0.01% to $1.2 billion in 2025, then retreated by 0.01% to $1.2 billion in 2026.
• The last three Total Debt figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.

Peer Comparison